| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
29,383 |
22,944 |
$2.10M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,430 |
15,344 |
$984K |
| 95144 |
|
1,039 |
166 |
$287K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
2,918 |
2,150 |
$224K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
2,733 |
2,061 |
$211K |
| 96136 |
|
4,142 |
3,186 |
$137K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
8,739 |
7,457 |
$101K |
| 90636 |
|
990 |
800 |
$100K |
| 90750 |
|
662 |
502 |
$99K |
| 99385 |
|
1,054 |
763 |
$96K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,453 |
4,409 |
$85K |
| 93000 |
|
2,841 |
2,291 |
$55K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
721 |
644 |
$54K |
| 96127 |
|
3,588 |
2,928 |
$52K |
| 99386 |
|
562 |
441 |
$50K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,263 |
1,053 |
$44K |
| 95250 |
|
531 |
403 |
$41K |
| 0001A |
|
955 |
937 |
$40K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
985 |
712 |
$40K |
| 0002A |
|
929 |
921 |
$39K |
| 90756 |
|
1,373 |
914 |
$38K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,251 |
2,890 |
$38K |
| 81003 |
|
18,209 |
13,628 |
$38K |
| 81025 |
|
8,007 |
5,882 |
$37K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
363 |
309 |
$34K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,512 |
949 |
$31K |
| 82962 |
|
16,363 |
10,759 |
$31K |
| 90688 |
|
1,723 |
1,312 |
$30K |
| 0012A |
|
714 |
694 |
$30K |
| 0011A |
|
764 |
684 |
$30K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
679 |
494 |
$28K |
| 90677 |
|
119 |
84 |
$26K |
| 90715 |
|
734 |
534 |
$22K |
| 80305 |
|
2,493 |
1,814 |
$22K |
| 91320 |
|
186 |
115 |
$21K |
| 90662 |
|
333 |
239 |
$18K |
| 0064A |
|
373 |
348 |
$18K |
| 0124A |
|
350 |
264 |
$15K |
| 99215 |
Prolong outpt/office vis |
268 |
230 |
$14K |
| 99406 |
|
2,875 |
2,014 |
$14K |
| 95923 |
|
173 |
107 |
$14K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
323 |
264 |
$13K |
| 0004A |
|
275 |
244 |
$11K |
| 99397 |
|
136 |
103 |
$11K |
| 95921 |
|
164 |
100 |
$9K |
| 90694 |
|
135 |
104 |
$9K |
| 93922 |
|
171 |
91 |
$8K |
| 0134A |
|
219 |
167 |
$8K |
| 90682 |
|
152 |
106 |
$8K |
| 90707 |
|
104 |
73 |
$7K |
| 82947 |
|
1,970 |
1,518 |
$7K |
| 81002 |
|
3,084 |
2,443 |
$7K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
115 |
78 |
$7K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
3,409 |
2,275 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
252 |
231 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
305 |
220 |
$4K |
| 94760 |
|
1,046 |
915 |
$4K |
| 99490 |
Ccm add 20min |
306 |
304 |
$3K |
| 0003A |
|
80 |
69 |
$3K |
| 0071A |
|
69 |
67 |
$3K |
| 69209 |
|
305 |
199 |
$3K |
| 36416 |
|
1,401 |
891 |
$3K |
| 0013A |
|
57 |
48 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,816 |
1,940 |
$2K |
| 0072A |
|
51 |
50 |
$2K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
27 |
27 |
$2K |
| 20610 |
|
54 |
36 |
$2K |
| 90480 |
|
46 |
40 |
$2K |
| 90686 |
|
185 |
153 |
$2K |
| 86328 |
|
25 |
24 |
$1K |
| 92540 |
|
23 |
18 |
$1K |
| 92546 |
|
62 |
22 |
$893.49 |
| 86580 |
|
192 |
135 |
$867.70 |
| 95251 |
|
34 |
26 |
$684.80 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
12 |
$667.03 |
| 85018 |
|
197 |
127 |
$450.82 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
249 |
168 |
$421.63 |
| J7626 |
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg |
245 |
173 |
$357.60 |
| 99173 |
|
83 |
78 |
$342.70 |
| 92547 |
|
26 |
21 |
$319.18 |
| 99072 |
|
435 |
369 |
$313.50 |
| 85014 |
|
123 |
84 |
$283.04 |
| 90620 |
|
19 |
13 |
$275.20 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
81 |
63 |
$99.25 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
216 |
200 |
$97.08 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
20 |
18 |
$67.20 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
85 |
71 |
$46.23 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
234 |
166 |
$16.58 |
| 91300 |
|
903 |
835 |
$3.81 |
| 91301 |
|
798 |
707 |
$3.24 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
314 |
250 |
$0.45 |
| 91312 |
|
113 |
90 |
$0.11 |
| 91313 |
|
54 |
41 |
$0.11 |
| 91306 |
|
25 |
25 |
$0.05 |
| 91307 |
|
36 |
33 |
$0.03 |
| 90461 |
|
16 |
14 |
$0.00 |